ARCHIVES

NCI advisors seek comment on clinical trials system, until Jan. 15.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

October 22, 2010

Concept Approval: NCI To Solicit “White Papers” For Technology Development Ideas

July 3, 1998

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

Clinical Trials Approved By NCI In November

December 28, 2001

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

Consensus Conference Suggest Research Required For Advances In Pain Control

May 30, 1986